There has been increasing interest in understanding the role of the human gut microbiome
to elucidate the therapeutic potential of its manipulation. Fecal microbiota transplantation (…

… that were absent in patients with relapsing CDI (the 3 Bacteroides strains) and on data from
in vitro assays for bacteria that inhibit C difficile (R productus, C bifermentans, and 1 of the E …

Increasing evidence indicates that the complex microbial ecosystem of the human intestine
plays a critical role in protecting the host against disease. This review discusses gut …

Background Fecal bacteriotherapy (‘stool transplant’) can be effective in treating recurrent
Clostridium difficile infection, but concerns of donor infection transmission and patient …

… (e) Comparison of antibiotic exposure time between control and NEC groups. In all
panels, asterisk indicates statistical significance at P<0.05. NEC, necrotizing enterocolitis. …

… Dr Petrof reported holding a patent for synthetic stool formation. Dr Crowther reported receiving
grants from the Heart and Stroke Foundation of Ontario, Leo Pharma, and Bayer, as well …

… (50 ng/mL) 6 hours before harvest, and compared with untreated control cells (No Tx), cells
treated with TNF-α alone (TNF-α only), or cells pretreated with conditioned media from the E …

Conditioned media from the probiotic Lactobacillus GG (LGG-CM) induce heat shock protein
(Hsp) expression in intestinal epithelial cells. LGG-CM induces both Hsp25 and Hsp72 in a …

… (E) Bacterial community of faecal samples from VDR ΔIEC and VDR loxP/loxP mice
using 454 16S rRNA sequencing data (n=4/group). (F) Representative fluorescence in situ …

… A recent study in enteropathogenic E. coli indicated that enteropathogenic E. coli-induced
inflammation involves a balance between pro- and anti-inflammatory proteins. Extracellular …